PB
Psyence Biomedical Ltd.
PBM · NASDAQ
$6.63 +4.83% (+$0.31)
1M +57.11%
Market Cap $126.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 58.93%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 36.81%
ROA 39.48%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 14.62x
Int. coverage -727.46x
Stability
6 /100
Unstable Beta 1.72x
EPS volatility 666.33%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o PBM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jody Aufrichtig
Employees
12
Headquarters
Toronto